Caryn Peterson
General Counsel at GOSSAMER BIO, INC.
Net worth: 58 803 $ as of 2024-03-30
Profile
Caryn L.
Peterson is the founder of DSC Associates LLC, which was founded in 2004.
She held the title of Managing Partner from 2004 to 2018.
Ms. Peterson's current job(s) include Chief Executive Officer at Alevium Pharmaceuticals, Inc. since 2009, Director at Aspen Neuroscience, Inc. since 2021, and Executive Vice President-Regulatory Affairs at Gossamer Bio, Inc. since 2018.
Ms. Peterson's former job(s) include Associate Director-Regulatory Affairs at Amylin Pharmaceuticals, Inc. from 1989 to 1997, Principal at Hybritech, Inc. from 1981 to 1989, Vice President-Regulatory Affairs at Syndax Pharmaceuticals, Inc. from 2008 to 2018, Vice President-Regulatory Affairs at OncoSec Medical, Inc., Vice President-Regulatory Affairs at Ascenta Therapeutics, Inc., and Vice President-Regulatory Affairs at FeRx, Inc. from 1997 to 2004.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GOSSAMER BIO, INC.
0.02% | 2024-03-17 | 49,833 ( 0.02% ) | 58 803 $ | 2024-03-30 |
Caryn Peterson active positions
| Companies | Position | Start |
|---|---|---|
| GOSSAMER BIO, INC. | General Counsel | 2017-12-31 |
| Alevium Pharmaceuticals, Inc. | Chief Executive Officer | 2009-05-31 |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Director/Board Member | 2021-06-22 |
Former positions of Caryn Peterson
| Companies | Position | End |
|---|---|---|
| DSC Associates LLC | Founder | 2017-12-31 |
| SYNDAX PHARMACEUTICALS, INC. | General Counsel | 2017-12-31 |
FeRx, Inc.
 FeRx, Inc. Medical SpecialtiesHealth Technology FeRx Inc. develops, manufactures, and distributes magnetic targeted carrier technology for the treatment of cancer. Its technology is used in therapeutic areas and provides technology platform for delivery of small molecules, radionuclides, biologics and genetic vectors. The company was registered in 1997 and is headquartered in San Diego, CA. | General Counsel | 2003-12-31 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | General Counsel | 1996-12-31 |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 1988-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| GOSSAMER BIO, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Health Technology |
FeRx, Inc.
FeRx, Inc. Medical SpecialtiesHealth Technology FeRx Inc. develops, manufactures, and distributes magnetic targeted carrier technology for the treatment of cancer. Its technology is used in therapeutic areas and provides technology platform for delivery of small molecules, radionuclides, biologics and genetic vectors. The company was registered in 1997 and is headquartered in San Diego, CA. | Health Technology |
| Alevium Pharmaceuticals, Inc. | |
| DSC Associates LLC | |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Health Services |
- Stock Market
- Insiders
- Caryn Peterson
